Aricept for Dementia Associated with Cerebral Vascular Disease

Completed

Phase 3 Results

Summary of Purpose

To study the effects of donepezil (AriceptĀ®) on dementia associated with cerebral vascular disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Eisai Inc.

Trial Design

Two multinational, double-blind, placebo-controlled trials with a planned enrollment of 1200 patients; 24-week follow-up.

Contacts

  • Johanna Garcia, Hill & Knowlton.

    david.wilkinson@wht.nhs.uk